Li Lixiang, Peng Hui, Li Ziyi, Zhou Fuhai, Yu Qingsheng
Department of Hepatobiliary Surgery, Lujiang County People's Hospital, Hefei, China.
Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Cytojournal. 2024 Dec 31;21:83. doi: 10.25259/Cytojournal_193_2024. eCollection 2024.
Intrahepatic cholangiolithiasis (Intrahepatic bile duct stones, IBDSs) is a common hepatobiliary disease characterized by bile duct obstruction and inflammation, often leading to severe complications such as cholangitis, cirrhosis, and cholangiocarcinoma. This study investigates the role of fat mass and obesity-associated (FTO) protein, an RNA demethylase, in regulating Kupffer cell (KC) polarization, interleukin (IL)-6 secretion, and subsequent human intrahepatic biliary epithelial cell (HiBEC) proliferation in IBDS.
Liver tissues from patients with IBDS were analyzed for FTO expression, KC M2 polarization, and IL-6 levels. experiments with FTO silencing in KCs were conducted to examine the effects on M2 polarization, IL-6 production, and HiBEC proliferation. Mechanistic analysis focused on the c-Jun N-terminal kinase (JNK)/p38 and phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathways.
The patients with IBDS showed significantly higher KC M2 polarization, elevated FTO expression, and increased IL-6 levels relative to the controls. Without FTO silencing, IL-6 secretion and HiBEC proliferation remained at high baseline levels. However, FTO silencing reduced M2 polarization, IL-6 secretion, and HiBEC proliferation through the JNK/p38 pathway. Activating the PI3K/AKT pathway partially reversed these inhibitory effects.
FTO plays a critical role in IBDS by promoting the M2 polarization of KCs, which leads to increased IL-6 secretion and induced pathological HiBEC proliferation. Targeting FTO may represent a novel therapeutic strategy for managing IBDS and preventing disease progression.
肝内胆管结石(肝内胆管结石,IBDS)是一种常见的肝胆疾病,其特征为胆管梗阻和炎症,常导致严重并发症,如胆管炎、肝硬化和胆管癌。本研究调查脂肪量与肥胖相关(FTO)蛋白(一种RNA去甲基化酶)在调节肝内胆管结石中库普弗细胞(KC)极化、白细胞介素(IL)-6分泌以及随后人类肝内胆管上皮细胞(HiBEC)增殖中的作用。
分析IBDS患者的肝组织中FTO表达、KC M2极化和IL-6水平。进行KC中FTO沉默实验,以检查对M2极化、IL-6产生和HiBEC增殖的影响。机制分析聚焦于c-Jun氨基末端激酶(JNK)/p38和磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(AKT)途径。
与对照组相比,IBDS患者的KC M2极化显著更高,FTO表达升高,IL-6水平增加。在未进行FTO沉默的情况下,IL-6分泌和HiBEC增殖保持在高基线水平。然而,FTO沉默通过JNK/p38途径降低了M2极化、IL-6分泌和HiBEC增殖。激活PI3K/AKT途径部分逆转了这些抑制作用。
FTO通过促进KC的M2极化在IBDS中起关键作用,这导致IL-6分泌增加并诱导病理性HiBEC增殖。靶向FTO可能代表一种治疗IBDS和预防疾病进展的新治疗策略。